Concert Pharmaceuticals (FRA:73C) Total Stockholders Equity : €134.61 Mil (As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Concert Pharmaceuticals Total Stockholders Equity?

Concert Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2022 was €134.61 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Concert Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2022 was €2.81. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Concert Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2022 was 0.11.

Concert Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Concert Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concert Pharmaceuticals Total Stockholders Equity Chart

Concert Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Stockholders Equity

Get a 7-Day Free Trial

165.99

147.44

91.31

107.82

99.32

Concert Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Stockholders Equity	Get a 7-Day Free Trial															84.29	99.32	69.52	120.89	134.61

Concert Pharmaceuticals (FRA:73C) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Concert Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(134.605	-	0)	/	47.9347
	=	2.81

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Concert Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.358	+	12.997)	/	134.605
	=	0.11

Concert Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Concert Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Concert Pharmaceuticals (FRA:73C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concert Pharmaceuticals Inc (FRA:73C) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Hayden Avenue, Suite 3000N, Lexington, MA, USA, 02421

Website

https://www.concertpharma.com

Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the currently approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.

Concert Pharmaceuticals (FRA:73C) Headlines

No Headlines